IRM financial statements and SEC filings
IRM annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $6.90B | $1.16B | $144.59M | 10-K |
| 2024-12-31 | $6.15B | $1.01B | $180.16M | 10-K |
| 2023-12-31 | $5.48B | $921.78M | $184.23M | 10-K |
| 2022-12-31 | $5.10B | $1.05B | $556.98M | 10-K |
| 2021-12-31 | $4.49B | $854.17M | $450.22M | 10-K |
| 2020-12-31 | $4.15B | $934.78M | $342.69M | 10-K |
IRM annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $21.13B | $21.77B | -$709.33M | 10-Q |
| 2024-12-31 | $18.72B | $18.94B | -$304.67M | 10-K |
| 2023-12-31 | $17.47B | $17.08B | $211.77M | 10-K |
| 2022-12-31 | $16.14B | $15.41B | $636.79M | 10-K |
| 2021-12-31 | $14.45B | $13.52B | $857.07M | 10-K |
| 2020-12-31 | $14.15B | $12.95B | $1.14B | 10-K |
IRM annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $1.34B | -$2.27B | $1.27B | 10-K |
| 2024-12-31 | $1.20B | -$1.79B | $876.75M | 10-K |
| 2023-12-31 | $1.11B | -$1.34B | $425.67M | 10-K |
| 2022-12-31 | $927.70M | -$875.38M | $639.21M | 10-K |
| 2021-12-31 | $758.90M | -$611.08M | -$220.81M | 10-K |
| 2020-12-31 | $987.66M | -$438.26M | -$886.70M | 10-K |